Bio-Techne Unveils Enhanced Leo System for Advanced High-Throughput Protein Analysis
Bio-Techne Corporation has announced the expanded launch and first shipment of its next-generation Leo™ System, an advanced protein analysis platform powered by Simple Western™ Technology. The enhanced Leo System features dual-channel fluorescence and chemiluminescence detection, enabling researchers to analyze up to 24 protein targets per sample and process up to 100 capillaries within three hours. This investment in high-throughput, multiplexed protein analysis strengthens Bio-Techne's leadership in proteomic analytical instruments and supports compliance with 21 CFR Part 11. The new system is designed to accelerate research workflows and provide highly precise results, expanding Bio-Techne's capabilities in the life sciences sector.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bio-Techne Corporation published the original content used to generate this news brief via PR Newswire (Ref. ID: CG41626) on December 09, 2025, and is solely responsible for the information contained therein.
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。